Ubrogepant found to be effective at reducing non-headache related symptoms of migraine
New research from King’s College London has found that ubrogepant – a drug used to manage migraine attacks – can effectively reduce the non-headache related symptoms when taken one to six hours prior to a migraine headache beginning.
By NIHR Maudsley BRC at 14 May 2025